File #003: From Fast Data to Faster Drugs — Thomas Wood on AI for Clinical Trials
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
File #003: From Fast Data to Faster Drugs — Thomas Wood on AI for Clinical Trials
-
Lu par :
-
De :
À propos de ce contenu audio
Physicist-turned-NLP expert Thomas Wood joins hosts Karin and Taymeyah to explore how artificial intelligence is shortening the road from protocol to patient. Thomas recounts founding Fast Data Science, explains why a Bill & Melinda Gates Foundation grant sparked his open-source Clinical Trial Risk Tool, and reveals the AI workflows already cutting months—and millions—from large pharma studies. The panel marks Alan Turing’s 113th birthday, trades “one thing I wish AI could do today,” and tackles myths around machine learning in healthcare. Looking ahead five-to-ten years, Thomas sketches a future of decentralised, patient-centric trials, but warns of regulatory and data-governance hurdles that still loom. New to the field? Stick around for book picks, career tips and a closing thought experiment for Turing himself.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !